Within two to four weeks we find potential targets/biomarker candidates or do a detailed target/biomarker assessment. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll contact you to discuss next steps.

Use our platform to find novel target/biomarker candidates or do detailed target/biomarker assessment yourselves. This will save you months of painstaking on-line desk research. Enter your contact details and we’ll set up a demo to show you!

Please contact me to discuss:

Subscription to Euretos AI Platform
Euretos consulting service
Direct access to Euretos API

Do you have a question on gene-disease associations that are not covered on this page? Or would you like to know more about the Euretos AI Platform? Please fill in your contact details and we will reach out to you!




Euretos AI Platform uncovers disease mechanism for novel melanoma target



Friday 07 September 2018

In a recent study published in the Biomedicine & Pharmacotherapy journal, researchers identified TPX2 as a novel potential target for melanoma. The study found that TPX2 promotes the proliferation of melanoma cells and that inhibition of TPX2 decreases melanoma cell proliferation.

This one of the first times that TPX2 is associated with Melanoma and little is known regarding its involvement in this particular from of cancer. Using the Euretos AI Platform, however, an exhaustive analysis of known direct and indirect associations between TPX2 and melanoma shows several key aspects of the disease mechanism.

Using the semantic search engine, it becomes clear that there is already literature on TPX2’s involvement in neoplastic processes. It is mentioned in the context of a number of cancers and key processes such as metastasis, neoplastic cell transformation, tumor progression and carcinogenesis:

Figure 1: Search result of TPX2 and associated neoplastic disorders and processes (source: Euretos AI Platform)

When searching for melanoma, no direct references are available in Pubmed. The Euretos AI platform, however, offers the option to analyse the involvement of any gene in any disease regardless of direct involvement. The platform leverages over 250 semantically integrated data sources and looks for associations based on the interacting genes with TPX2 to assess it’s indirect effects. This workflow shows that TPX2 interacts with hundreds of genes that are also associated with melanoma:

 

Figure 2: Gene-Disease Analysis workflow showing genes that are associated with TPX2 as well as melanoma (source: Euretos AI Platform)

Using this ‘gene interactome’ as the basis for further analysis, various aspects are evaluated including involvement in melanoma related differential expression, gene mutations, animal models, metabolic interactions and key physiological processes such as pathways, phenotypes, molecular dysfunctions and cell & tissue functions.

In terms of dysregulation, TPX2 is itself dysregulated in various differential expression experiments for melanoma. Also, it is co-expressed with many other genes (only the top 15 are displayed) in the context of melanoma:

 

Figure 3: Dysregulation analysis of TPX2 and its melanoma specific interactome (source: Euretos AI Platform)

The Gene-Disease Analysis workflow also provides an analysis of key physiological processes such as pathways, phenotypes, molecular dysfunctions and cell & tissue functions. The top 5 physiological processes are highlighted in which TPX2 plays a role and which are also most associated with melanoma.

The Pathway analysis shows that TPX2 exerts its influence through various indirect interactions such as the G2 phase pathway and the innate immune system, both well known aspects of tumor development and growth in melanoma.

 

Figure 4: Pathway analysis of TPX2 and its gene interactome revealing key associations with melanoma (source: Euretos AI Platform)

In the area of cell and molecular dysfunctions, TPX2 is involved in cytotoxicity and DNA damage, which is closely related to processes such as proliferation, migration, invasion, metastasis that are mentioned in the article.

Figure 5: Cell & Molecular Dysfunctions analysis of TPX2 and its gene interactome revealing key associations with melanoma (source: Euretos AI Platform)

At the organ and tissue function level, finally, TPX2 is involved in skin pigmentation, which is relevant at the early stages of melanoma, and the immune response, a key aspect to tumor survival.

Figure 6: Organ & Tissue Function analysis of TPX2 and its gene interactome revealing key associations with melanoma (source: Euretos AI Platform)

In conclusion, although very limited direct literature exists of the involvement of TPX2 in melanoma, the Gene-Disease Analysis workflow reveals many relevant associations with melanoma. Through its gene interactions TPX2 is involved in various mechanisms that are key tumorigenesis, tumor growth, metastasis and survival.

The full analysis is available on request via the contact form on the Euretos website or at information@euretos.com

Read more news articles: Euretos News

About this series - The purpose of the Euretos Research Note series is to provide a data analytics perspective on recent life sciences publications. The series focuses on two types of questions: (1) Did the available data already point in the direction of a discovery? (2) What further research angles does the available data suggest?